Table 1.
Clinical relevance of 93 cases of osteoarticular infections due to Streptococcus species
Characteristic | Total (n = 93), n (%) | Monomicrobial infection (n = 34), n (%) | Polymicrobial infection (n = 59), n (%) |
---|---|---|---|
Sex | |||
Female | 16 (17) | 6 (18) | 10 (17) |
Male | 77 (83) | 28 (82) | 49 (83) |
Comorbidities and risk factors | 84 (90) | 25 (74) | 59 (100) |
Diabetes mellitus | 34 (37) | 10 (29) | 24 (41) |
Tobacco use | 28 (30) | 10 (29) | 18 (31) |
Peripheral arterial disease | 27 (29) | 6 (18) | 21 (36) |
Peripheral neuropathy | 21 (23) | 1 (3) | 20 (34) |
Malignancy | 15 (16) | 6 (18) | 9 (15) |
Haematologic malignancy | 4 (4) | 3 (9) | 1 (2) |
Solid cancer | 11 (12) | 3 (9) | 8 (14) |
Chronic liver disease | 10 (11) | 1 (3) | 9 (15) |
Immunodeficiency | 9 (10) | 5 (15) | 4 (7) |
Corticosteroid treatment | 4 (4) | 1 (3) | 3 (5) |
Asplenia | 2 (2) | 2 (6) | 0 |
HIV infection | 2 (2) | 0 | 2 (3) |
Alcoholism | 7 (8) | 0 | 7 (12) |
Inflammatory rheumatism | 5 (5) | 2 (6) | 3 (5) |
Pneumonia | 3 (3) | 1 (3) | 2 (3) |
Intravenous drug users | 2 (2) | 1 (3) | 1 (2) |
Chronic wound | 42 (45) | 1 (3) | 41 (69) |
Closed fracture | 22 (24) | 4 (12) | 18 (31) |
Open fracture | 8 (9) | 3 (9) | 5 (8) |
Clinical and biological presentation | |||
Local inflammation | 64 (69) | 22 (65) | 42 (71) |
Purulent discharge inside wound | 57 (61) | 9 (26) | 48 (81) |
Fever | 40 (43) | 20 (59) | 20 (34) |
Erysipelas | 13 (14) | 2 (6) | 11 (19) |
Bacteraemia | 13 (14) | 6 (18) | 7 (12) |
Severe sepsis | 3 (3) | 2 (6) | 1 (2) |
Endocarditis | 3 (3) | 3 (9) | 0 |
C-reactive protein rate ≥40 mg/mL | 73 (79) | 28 (82) | 45 (76) |
Type of infection | |||
Without orthopaedic devicea | 60 (65) | 17 (50) | 46 (78) |
Osteitis | 42 (45) | 4 (12) | 38 (64) |
Arthritis | 12 (13) | 8 (24) | 4 (7) |
Vertebral osteomyelitis | 9 (10) | 5 (15) | 4 (7) |
With orthopaedic deviceb | 33 (35) | 17 (50) | 16 (27) |
Internal osteosynthesis device infection | 17 (18) | 8 (24) | 9 (15) |
Joint prosthesis infection | 14 (15) | 8 (24) | 6 (10) |
Vertebral osteosynthesis device infection | 3 (3) | 1 (3) | 2 (3) |
Infection localization | |||
Foot | 31 (33) | 2 (6) | 29 (49) |
Knee | 15 (16) | 9 (26) | 6 (10) |
Tibia | 14 (15) | 6 (18) | 8 (14) |
Vertebra | 12 (13) | 8 (24) | 4 (7) |
Hip | 9 (10) | 5 (15) | 4 (7) |
Ankle | 8 (9) | 4 (12) | 4 (7) |
Hand | 4 (4) | 0 | 4 (7) |
Wrist | 2 (2) | 2 (6) | 0 |
Sternoclavicular | 1 (1) | 1 (3) | 0 |
Shoulder | 1 (1) | 1 (3) | 0 |
Femur | 1 (1) | 0 (0) | 1 (2) |
Pelvis | 2 (2) | 1 (3) | 1 (2) |
Multiple localization | 6 (6) | 4 (12) | 2 (3) |
Orthopaedic device infection delays | |||
Early infection (month 1) | 4 (12) | 1 (6) | 3 (19) |
Delayed infection (months 2–6) | 6 (18) | 4 (24) | 2 (13) |
Late infection (more than month 6) | 23 (70) | 12 (71) | 11 (69) |
Three vertebral infections without osteosynthesis were associated with osteitis and arthritis in one and two, respectively.
One vertebral osteosynthesis device infection was associated with osteitis with internal osteosynthesis device infection.